Description
Altiratinib is an inhibitor of c-MET, Tie-2, and VEGFR that exhibits anticancer chemotherapeutic activity. In ovarian cancer models, this compound inhibits cell growth and migration and decreases tumor burden.
Product Unit Size | Cost | Quantity | Stock |
---|
Altiratinib is an inhibitor of c-MET, Tie-2, and VEGFR that exhibits anticancer chemotherapeutic activity. In ovarian cancer models, this compound inhibits cell growth and migration and decreases tumor burden.
Cas No. | 1345847-93-9 |
---|---|
Purity | ≥98% |
Formula | C26H21F3N4O4 |
Formula Wt. | 510.46 |
Chemical Name | 1-N'-[4-[2-(cyclopropanecarbonylamino)pyridin-4-yl]oxy-2,5-difluorophenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide |
IUPAC Name | N-[4-({2-[(Cyclopropylcarbonyl)amino]-4-pyridinyl}oxy)-2,5-difluorophenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide |
Synonym | DCC-2701, DP-5164 |
Solubility | DMSO: 33mg/mL |
Store Temp | Ambient |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Kwon Y, Smith BD, Zhou Y, et al. Effective inhibition of c-MET-mediated signaling, growth and migration of ovarian cancer cells is influenced by the ovarian tissue microenvironment. Oncogene. 2015 Jan 8;34(2):144-53. PMID: 24362531.
Steroidal alkaloid found in Veratrum and Fritil...
α4β2 nAChR desensitizer, delayed-rectifier vo...
Histamine H1 antagonist.
First generation fluoroquinolone antibiotic.
N-acetyl cysteine conjugate of phenethylisothio...
NSAID; COX-1/2 inhibitor.
TrkB agonist.
Dibenzofuran produced by lichens.
Diterpenoid epoxide found in Tripterygium.
Bisphosphonate; squalene synthase inhibitor.
Bone deterioration inhibitor, potential CaR ago...
Tripeptide, binds cell surface integrins.
Endogenous opioid peptide; μOR agonist.
Polyphenol found in various plants and foods.
Isoflavone daidzein derivative found in Puerari...
Src and Abl inhibitor.
Indole, glucosinolate found in cruciferous vege...
Diterpene cafestol derivative found in coffee b...
Neuraminidase inhibitor.
Selective inhibitor of protein kinase C (PKC).<...